{"pub": "businessinsider", "url": "https://businessinsider.com/healthcare-and-biotech-unicorns-going-into-2019-venture-capital-i2018-12", "downloaded_at": "2019-09-04 00:36:07.684053+00:00", "title": "The 19 billion-dollar startups to watch that are revolutionizing healthcare in 2019", "language": "en", "published_at": "2019-09-03", "text": "For private (and now public) healthcare and biotech companies, 2018 was a great year to raise capital with 16 companies reaching unicorn status. So far, in 2019, three more companies have been added to the list.\n\nHealth Catalyst, which went public in July, Lyell Therapeutics and Rakuten Medical all reached the $1 billion valuation mark.\n\nSome significant changes happened in 2019, with Auris Health getting bought by Johnson & Johnson for $3.4 billion in February 2019, marking the company's valuation at over $5 billion. Tempus, the healthcare analytics platform, increased its valuation to $3 billion after less than four years. The health-insurance startup, Oscar Health, also announced plans to expand the company in 12 new markets next year.\n\nAccording to data from PitchBook, here are the top-valued healthcare companies of 2019.\n\nThis list was initially published in December 2018 and has been updated.\n\nNever miss out on healthcare news. Subscribe to Dispensed, our weekly newsletter on pharma, biotech, and healthcare.", "description": "These are the top-valued private biotech and healthcare companies in 2019, according to PitchBook.", "authors": ["Lydia Ramsey", "Clarrie Feinstein"], "top_image": "https://amp.businessinsider.com/images/5b5720d97d4dc72e008b45fd-1920-960.jpg"}